Ashwin Sharma (@Ashwinreads) — Software on X (Twitter)

Ashwin Sharma is a Software creator on X (Twitter) in the 10K–20K follower range, publishing for GLP-1 biotech researchers, D2C health founders, and biotech equity investors. Profile last checked 2026-07-03.

| Field | Value |

| --- | --- |

| Platform | X (Twitter) |

| Handle | @Ashwinreads |

| Followers | 10K–20K |

| Category | Software |

Profile bio

Founder @glp1digest / D2C & GLP-1 biotech research: https://t.co/upg2T0iLea / Building https://t.co/NWwzeoUwvU / Writing @every / MD & Ex-VC fellow

What this creator posts about, and who reads it

Recurring topics: GLP-1 biotech research, D2C health products, biotech equity analysis

Audience: GLP-1 biotech researchers, D2C health founders, and biotech equity investors

Audience read from this creator’s own recent posts, not from platform-declared categories. It is our reading, and it can be wrong.

Recent content samples

🚨podcast dropping soon! i had the opportunity to speak with the wonderful emily field, head of biotech equity research at @barclays investment bank. we discussed: - the DTC price of retatrutide - what % of the glp-1…

Shotsy has 350,000 monthly active GLP-1 users on its' app. Roughly one-third pay are paying annual subscriptions which is pretty darn good for a freemium app service. And, even better, the customer acquisition costs are…

See the original post on X (Twitter)

Where this creator sits in the wider pool

Koinon Link indexes X (Twitter) creators in Software with grade, authenticity and contactability broken down — see the X (Twitter) × Software breakdown, or the Creator Index Report for the whole index.

This page lists public profile information only. It carries no contact details and no authenticity score. If you are Ashwin Sharma and want this page removed, request removal.